New flu vaccine shows promise in large trial
NCT ID NCT05569239
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single dose of a new flu vaccine called OVX836 in about 2,850 healthy adults aged 18 to 59. The goal is to see if it can prevent confirmed influenza A and how safe it is. Participants will be randomly assigned to receive either the vaccine or a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FI-14
Kokkola, Finland
-
Site BE-01
Ghent, Belgium
-
Site BE-02
Antwerp, Belgium
-
Site BE-03
Antwerp, Belgium
-
Site BE-04
Mechelen, Belgium
-
Site DE-16
München, Germany
-
Site FI-08
Helsinki, Finland
-
Site FI-09
Tampere, Finland
-
Site FI-10
Turku, Finland
-
Site FI-11
Oulu, Finland
-
Site FI-12
Espoo, Finland
-
Site FI-13
Jarvenpaa, Finland
-
Site FI-15
Seinäjoki, Finland
-
Site FR-05
Lyon, France
-
Site FR-06
Rennes, France
-
Site FR-07
Paris, France